BlackRock Inc. trimmed its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS) by 1.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,067,817 shares of the company’s stock after selling 75,590 shares during the quarter. BlackRock Inc. owned about 10.91% of Nu Skin Enterprises worth $500,109,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in NUS. OppenheimerFunds Inc. increased its holdings in Nu Skin Enterprises by 80.5% in the 2nd quarter. OppenheimerFunds Inc. now owns 267,285 shares of the company’s stock valued at $20,899,000 after purchasing an additional 119,244 shares during the last quarter. Oregon Public Employees Retirement Fund increased its holdings in Nu Skin Enterprises by 16.3% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 21,674 shares of the company’s stock valued at $1,695,000 after purchasing an additional 3,038 shares during the last quarter. ING Groep NV increased its holdings in Nu Skin Enterprises by 12.9% in the 2nd quarter. ING Groep NV now owns 8,518 shares of the company’s stock valued at $666,000 after purchasing an additional 976 shares during the last quarter. RBO & Co. LLC acquired a new stake in Nu Skin Enterprises in the 2nd quarter valued at approximately $227,000. Finally, Barings LLC increased its holdings in Nu Skin Enterprises by 342.8% in the 2nd quarter. Barings LLC now owns 24,930 shares of the company’s stock valued at $1,949,000 after purchasing an additional 19,300 shares during the last quarter. 74.66% of the stock is currently owned by institutional investors and hedge funds.
Several analysts recently weighed in on the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $98.00 target price on shares of Nu Skin Enterprises in a report on Tuesday, September 4th. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Tuesday, October 23rd. Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a report on Wednesday, November 21st. Citigroup set a $88.00 target price on shares of Nu Skin Enterprises and gave the company a “buy” rating in a report on Thursday, November 8th. Finally, Bank of America reiterated an “underperform” rating and issued a $65.00 target price (down previously from $75.00) on shares of Nu Skin Enterprises in a report on Thursday. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $83.63.
NYSE:NUS opened at $63.78 on Friday. The firm has a market capitalization of $3.60 billion, a price-to-earnings ratio of 19.75, a price-to-earnings-growth ratio of 1.64 and a beta of 0.99. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.93 and a quick ratio of 1.25. Nu Skin Enterprises, Inc. has a 52 week low of $60.60 and a 52 week high of $88.68.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, November 7th. The company reported $0.94 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.02). The business had revenue of $675.31 million during the quarter, compared to analyst estimates of $664.99 million. Nu Skin Enterprises had a return on equity of 27.50% and a net margin of 5.93%. The business’s revenue was up 19.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.76 EPS. On average, sell-side analysts anticipate that Nu Skin Enterprises, Inc. will post 3.51 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Friday, November 30th will be paid a $0.365 dividend. The ex-dividend date is Thursday, November 29th. This represents a $1.46 annualized dividend and a dividend yield of 2.29%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 45.20%.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,500 shares of the business’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $67.53, for a total value of $168,825.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last 90 days, insiders sold 7,500 shares of company stock valued at $537,625. Insiders own 5.20% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This story was reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/12/08/blackrock-inc-decreases-holdings-in-nu-skin-enterprises-inc-nus.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Article: Put Option
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.